← All organizations
Highest phase reached
Phase 2
First clinical trial
May 31, 2017Last known activity
Jan 31, 2020
Timeline
2010s
- Jun 1, 2015
Castle Creek Pharmaceuticals— Founded
- Sep 12, 2019
Fibrocell Technologies, Inc.— Acquired
Drugs by trial phase (5 distinct, 18 trials)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (10)
- NCT04213261CollaboratorPhase 3Jan 31, 2020
- NCT03472287Lead sponsorPhase 1May 10, 2018
- NCT03472547Lead sponsorPhase 1Jan 15, 2018
- NCT03472534Lead sponsorPhase 1Jan 9, 2018
- NCT03473197Lead sponsorPhase 1Jan 8, 2018
- NCT03473184Lead sponsorPhase 1Dec 12, 2017
- NCT03389308Study directorPhase 2Dec 1, 2017
- NCT03389308Lead sponsorPhase 2Dec 1, 2017
- NCT03154333Lead sponsorPhase 2May 31, 2017
- NCT03154333Study directorPhase 2May 31, 2017
Details
- Founded
- Bedminster, NJ, US Jun 1, 2015
- Last known activity
- Jan 31, 2020